These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 38025464)

  • 1. Leveraging iPSC technology to assess neuro-immune interactions in neurological and psychiatric disorders.
    Michalski C; Wen Z
    Front Psychiatry; 2023; 14():1291115. PubMed ID: 38025464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
    Prem S; Millonig JH; DiCicco-Bloom E
    Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studying Heterotypic Cell⁻Cell Interactions in the Human Brain Using Pluripotent Stem Cell Models for Neurodegeneration.
    Song L; Yan Y; Marzano M; Li Y
    Cells; 2019 Apr; 8(4):. PubMed ID: 30939814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of reprogrammed patient cells to investigate the etiology of neurological and psychiatric disorders.
    Christian KM; Song H; Ming GL
    Front Biol (Beijing); 2012 Jun; 7(3):179-188. PubMed ID: 34603405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine iPSC-derived microglia and macrophage cell culture models recapitulate distinct phenotypical and functional properties of classical and alternative neuro-immune polarisation.
    Quarta A; Le Blon D; D'aes T; Pieters Z; Hamzei Taj S; Miró-Mur F; Luyckx E; Van Breedam E; Daans J; Goossens H; Dewilde S; Hens N; Pasque V; Planas AM; Hoehn M; Berneman Z; Ponsaerts P
    Brain Behav Immun; 2019 Nov; 82():406-421. PubMed ID: 31525508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central nervous system organoids for modeling neurodegenerative diseases.
    Hou PS; Kuo HC
    IUBMB Life; 2022 Aug; 74(8):812-825. PubMed ID: 35102668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic and immune dysfunction of glia in neurodegenerative disorders: Focus on iPSC models.
    Rõlova T; Lehtonen Š; Goldsteins G; Kettunen P; Koistinaho J
    Stem Cells; 2021 Mar; 39(3):256-265. PubMed ID: 33270954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. iPSC modeling of rare pediatric disorders.
    Freel BA; Sheets JN; Francis KR
    J Neurosci Methods; 2020 Feb; 332():108533. PubMed ID: 31811832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling Brain Disorders Using Induced Pluripotent Stem Cells.
    Vadodaria KC; Jones JR; Linker S; Gage FH
    Cold Spring Harb Perspect Biol; 2020 Jun; 12(6):. PubMed ID: 31767646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When glia meet induced pluripotent stem cells (iPSCs).
    Li L; Shi Y
    Mol Cell Neurosci; 2020 Dec; 109():103565. PubMed ID: 33068719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced Pluripotent Stem Cell (iPSC)-Based Neurodegenerative Disease Models for Phenotype Recapitulation and Drug Screening.
    Chang CY; Ting HC; Liu CA; Su HL; Chiou TW; Lin SZ; Harn HJ; Ho TJ
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32344649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of human microglial models for studies of HIV replication and pathogenesis.
    Rai MA; Hammonds J; Pujato M; Mayhew C; Roskin K; Spearman P
    Retrovirology; 2020 Nov; 17(1):35. PubMed ID: 33213476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
    Corti S; Faravelli I; Cardano M; Conti L
    Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mental health dished up-the use of iPSC models in neuropsychiatric research.
    McNeill RV; Ziegler GC; Radtke F; Nieberler M; Lesch KP; Kittel-Schneider S
    J Neural Transm (Vienna); 2020 Nov; 127(11):1547-1568. PubMed ID: 32377792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's in a dish - induced pluripotent stem cell-based disease modeling.
    de Leeuw S; Tackenberg C
    Transl Neurodegener; 2019; 8():21. PubMed ID: 31338163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shedding light on latent pathogenesis and pathophysiology of mental disorders: The potential of iPS cell technology.
    Arioka Y; Okumura H; Sakaguchi H; Ozaki N
    Psychiatry Clin Neurosci; 2023 Jun; 77(6):308-314. PubMed ID: 36929185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation.
    Giacomelli E; Vahsen BF; Calder EL; Xu Y; Scaber J; Gray E; Dafinca R; Talbot K; Studer L
    Cell Stem Cell; 2022 Jan; 29(1):11-35. PubMed ID: 34995492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine induced pluripotent stem cell-derived neuroimmune cell culture models emphasize opposite immune-effector functions of interleukin 13-primed microglia and macrophages in terms of neuroimmune toxicity.
    Quarta A; Meese T; Pieters Z; Van Breedam E; Le Blon D; Van Broeckhoven J; Hendrix S; Goossens H; Hens N; Berneman Z; Van Nieuwerburgh F; Ponsaerts P
    Glia; 2021 Feb; 69(2):326-345. PubMed ID: 32865285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The application of human pluripotent stem cells to model the neuronal and glial components of neurodevelopmental disorders.
    Lee KM; Hawi ZH; Parkington HC; Parish CL; Kumar PV; Polo JM; Bellgrove MA; Tong J
    Mol Psychiatry; 2020 Feb; 25(2):368-378. PubMed ID: 31455859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.